Update on molecular pathology of cutaneous melanocytic lesions; what is new in diagnosis and molecular testing for treatment?

In this article we give an update on recent findings regarding molecular pathology in cutaneous melanocytic tumours. The focus lies on use of genetics in the diagnosis of distinct subtypes of spitzoid tumours that are often characterized by specific phenotypic-genotypic alterations that can frequent...

Full description

Bibliographic Details
Main Author: Willeke eBlokx
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-10-01
Series:Frontiers in Medicine
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmed.2014.00039/full
id doaj-710e58ef968e4094b62010e66a2a5eb7
record_format Article
spelling doaj-710e58ef968e4094b62010e66a2a5eb72020-11-24T22:25:05ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2014-10-01110.3389/fmed.2014.00039120942Update on molecular pathology of cutaneous melanocytic lesions; what is new in diagnosis and molecular testing for treatment?Willeke eBlokx0Department of Pathology, Radboud University Medical CenterIn this article we give an update on recent findings regarding molecular pathology in cutaneous melanocytic tumours. The focus lies on use of genetics in the diagnosis of distinct subtypes of spitzoid tumours that are often characterized by specific phenotypic-genotypic alterations that can frequently be recognized by adequate histological examination. Typical illustrating cases are given in order to increase recognition of these lesions in daily dermatopathology practice. New molecular findings in the pathogenesis of congenital melanocytic tumours and neurocutaneous melanosis are reviewed. In addition use of mutation analysis in the differential diagnosis of melanoma metastasis is discussed. Finally application of mutation analysis in targeted therapy in advanced melanoma with advantages of new techniques such as next generation sequencing is described.http://journal.frontiersin.org/Journal/10.3389/fmed.2014.00039/fullMelanomatargeted therapyreviewMolecular pathologySpitzcongenital nevus
collection DOAJ
language English
format Article
sources DOAJ
author Willeke eBlokx
spellingShingle Willeke eBlokx
Update on molecular pathology of cutaneous melanocytic lesions; what is new in diagnosis and molecular testing for treatment?
Frontiers in Medicine
Melanoma
targeted therapy
review
Molecular pathology
Spitz
congenital nevus
author_facet Willeke eBlokx
author_sort Willeke eBlokx
title Update on molecular pathology of cutaneous melanocytic lesions; what is new in diagnosis and molecular testing for treatment?
title_short Update on molecular pathology of cutaneous melanocytic lesions; what is new in diagnosis and molecular testing for treatment?
title_full Update on molecular pathology of cutaneous melanocytic lesions; what is new in diagnosis and molecular testing for treatment?
title_fullStr Update on molecular pathology of cutaneous melanocytic lesions; what is new in diagnosis and molecular testing for treatment?
title_full_unstemmed Update on molecular pathology of cutaneous melanocytic lesions; what is new in diagnosis and molecular testing for treatment?
title_sort update on molecular pathology of cutaneous melanocytic lesions; what is new in diagnosis and molecular testing for treatment?
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2014-10-01
description In this article we give an update on recent findings regarding molecular pathology in cutaneous melanocytic tumours. The focus lies on use of genetics in the diagnosis of distinct subtypes of spitzoid tumours that are often characterized by specific phenotypic-genotypic alterations that can frequently be recognized by adequate histological examination. Typical illustrating cases are given in order to increase recognition of these lesions in daily dermatopathology practice. New molecular findings in the pathogenesis of congenital melanocytic tumours and neurocutaneous melanosis are reviewed. In addition use of mutation analysis in the differential diagnosis of melanoma metastasis is discussed. Finally application of mutation analysis in targeted therapy in advanced melanoma with advantages of new techniques such as next generation sequencing is described.
topic Melanoma
targeted therapy
review
Molecular pathology
Spitz
congenital nevus
url http://journal.frontiersin.org/Journal/10.3389/fmed.2014.00039/full
work_keys_str_mv AT willekeeblokx updateonmolecularpathologyofcutaneousmelanocyticlesionswhatisnewindiagnosisandmoleculartestingfortreatment
_version_ 1725759364849991680